同时准meni和LSD1可以拆除致癌方案,并恢复MLL重新排列的AML的差异化
Mina M Tayari1, Helena Gomes Dos Santos1, Felipe Beckedorff1
1Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Department of Human Genetics, Miami, FL, United States.
bioRxiv : the preprint server for biology
|November 24, 2025
概括
结合精氨酸和氨酸特异性脱甲酶1 (LSD1) 抑制,可用于治疗具有MLL重组的急性髓性白血病 (AML). 这种双重封锁的目标是关键的白血病途径,导致分化和减少瘤负担.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 具有MLL重组 (MLL-r) 的急性髓性白血病 (AML) 是一个高风险的亚型,结果不佳.
- 目前的脑膜抑制策略显示,作为单一药物,持续反应有限.
研究的目的:
- 为了确定MLL-rAML的有效组合疗法.
- 为了研究与表观遗传调节器的精子抑制的协同潜力.
主要方法:
- 在MLL-rAML模型中,高通量查>900个表观遗传调节器,并与肌肉抑制相结合.
- 机理学研究涉及染色体分析和蛋白质相互作用的评估.
- 使用MLL-rAML异种移植模型进行体内研究.
主要成果:
- 在meni和氨酸特异性去甲基酶1 (LSD1) 抑制之间观察到一致的协同作用.
- 通过LEDGF,LSD1被确定为一个与menin-MLL复合体相互作用的辅因子.
- 双抑制分解了染色体复合体,抑制了MLL点,并促进了髓状细胞的分化.
- 组合疗法表现出强烈的抗白血病作用和在体内延长生存时间,没有显著的毒性.
结论:
- 同时抑制menin和LSD1代表了对MLL-rAML的机理上明智的组合方法.
- 在 menin-MLL-LEDGF轴上,LSD1 是一个关键的辅因子.
- 这种组合策略需要对MLL-rAML治疗进行进一步的临床研究.
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:23Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K